MBIO:NASDAQ
Mustang Bio Inc
USD 0.42
arrow_downward
-1.98%(-0.0085) 1H
13 Nov, 4:00:00 PTG GMT-5 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk MBIO...
Buka
USD 0.44
Tinggi
USD 0.45
Rendah
USD 0.42
Permodalan Pasaran
3.23J
Purata volum
43.06K
Volum
19.47K
tgi 52 mgu
USD 1.43
rdh 52 mgu
USD 0.35
EPS
-USD 0.53
Beta
2.20
Syer tertunggak
6.74J
Bilangan pekerja
4
Buka
USD 0.44
Tinggi
USD 0.45
Rendah
USD 0.42
Permodalan Pasaran
3.23J
Purata volum
43.06K
Volum
19.47K
tgi 52 mgu
USD 1.43
rdh 52 mgu
USD 0.35
EPS
-USD 0.53
Beta
2.20
Syer tertunggak
6.74J
Bilangan pekerja
4
Cerita berita
Daripada sumber web dan rakan kongsi berita
investingLive
·
2 jam lalu
Morgan Stanley goes max overweight global stocks, sees 15% S&P 500 upside on AI capex
The Motley Fool
·
9 jam lalu
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
TradingKey
·
1 hari lalu
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
BigGo Finance
·
15 jam lalu
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
Profil
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Perihal Mustang Bio Inc
CEOManuel Litchman
Pekerja4
Diasaskan2015
Ibu pejabatWaltham, Massachusetts, Amerika Syarikat
SektorHealth Care
Industri-
Laman webmustangbio.com